Hereditary hemochromatosis is a genetic condition that causes your body to absorb too much iron from food. Because humans have no natural way to get rid of excess iron, it builds up over years in organs like the liver, heart, and pancreas, eventually causing serious damage if untreated. It is one of the most common inherited disorders among people of Northern European descent, affecting roughly 1 in 385 white Americans.
How Iron Regulation Breaks Down
Your body normally controls iron levels through a hormone called hepcidin, produced in the liver. Hepcidin acts as a gatekeeper: when iron stores are adequate, it signals cells in the gut to stop releasing iron into the bloodstream. It does this by binding to ferroportin, the only protein that exports iron out of cells. Once hepcidin locks onto ferroportin, the pair is pulled inside the cell and broken down, effectively shutting the iron door.
In hereditary hemochromatosis, a mutation in the HFE gene disrupts this system. The most common mutation, called C282Y, warps the shape of the HFE protein so it can no longer interact properly with the receptors on liver cells that trigger hepcidin production. The result is chronically low hepcidin. With the gatekeeper absent, ferroportin stays active on the surface of intestinal cells, continuously pumping dietary iron into the bloodstream. Over decades, this unchecked absorption can deposit tens of grams of excess iron throughout the body.
Genetics and Inheritance
Hereditary hemochromatosis follows an autosomal recessive pattern, meaning you need two copies of the mutated gene (one from each parent) to develop significant iron overload. About 5.4% of the U.S. population carries one copy of the C282Y mutation, and roughly 0.26% are homozygous, carrying two copies. A second, less severe variant called H63D is even more common, with a carrier frequency of 13.5%. People who inherit one C282Y and one H63D (compound heterozygotes) make up about 2% of the population, though they rarely develop full-blown iron overload.
The condition is most prevalent among people of Northern European ancestry. Among non-Hispanic white Americans, nearly 1 in 10 carries at least one copy of C282Y. The rate drops to about 2.3% in non-Hispanic Black Americans and 2.75% in Mexican Americans. Not everyone with two C282Y copies develops clinical disease. The actual expression varies widely depending on other genetic modifiers, diet, alcohol intake, and, notably, sex. Women are partly protected by iron losses through menstruation and pregnancy, which is why men tend to develop symptoms earlier and more severely.
Early and Late Symptoms
Iron accumulates slowly, so symptoms often don’t appear until middle age, typically between 40 and 60 in men and after menopause in women. Early signs are frustratingly vague: persistent fatigue, joint pain (especially in the knuckles of the first two fingers), abdominal discomfort, unexplained weight loss, and reduced sex drive. Many people attribute these to aging or stress, which is one reason the average diagnosis is delayed by years.
As iron deposits grow, the damage becomes more specific. The liver bears the heaviest burden, progressing from inflammation to fibrosis to cirrhosis and, in some cases, liver cancer. The pancreas can lose its ability to produce insulin, leading to diabetes. The skin may take on a bronze or grayish tone from iron deposits in the skin cells. This combination of cirrhosis, bronze skin, and diabetes was historically called “bronze diabetes” and remains the classic textbook description, though most patients today are caught before reaching that stage.
Heart and Endocrine Complications
Iron-overload cardiomyopathy accounts for roughly one-third of deaths in hereditary hemochromatosis, particularly in younger men. Excess iron in heart muscle cells generates free radicals that damage the tissue, leading to stiffening, rhythm abnormalities, and eventually heart failure. In the most severe juvenile form of the disease (caused by mutations in hepcidin itself rather than HFE), heart failure can develop before age 30.
The endocrine system is also vulnerable. Iron deposits in the pituitary gland can suppress production of hormones that control the thyroid and reproductive organs, causing hypothyroidism and hypogonadism. In men, this often presents as low testosterone, erectile dysfunction, and loss of body hair. These hormonal changes can appear before liver symptoms do, making them an important early clue.
Diagnosis and Family Screening
The initial screening involves two blood tests: serum ferritin, which reflects total body iron stores, and transferrin saturation, which measures how much of the blood’s iron-carrying protein is loaded with iron. A transferrin saturation consistently above 45% raises suspicion. Genetic testing for HFE mutations confirms the diagnosis.
Because hemochromatosis runs in families, genetic testing is recommended for all first-degree relatives (parents, siblings, and children) of anyone diagnosed. If only one parent carries the mutation, children do not need testing since they can inherit at most one copy and won’t develop the disease.
Treatment With Phlebotomy
The primary treatment is surprisingly simple: regularly removing blood. Each session draws 400 to 500 milliliters (roughly one pint), and each pint contains about 250 milligrams of iron. During the initial phase, you’ll typically have blood drawn weekly or every two weeks until iron levels normalize. This induction phase can take months to over a year depending on how much iron has accumulated.
Once ferritin drops to the target range, you move to a maintenance schedule. The frequency varies widely from person to person, anywhere from once a month to once a year. Some people find the sessions tiring for a day or two afterward, but the procedure itself is quick, safe, and inexpensive.
Timing matters enormously. When phlebotomy begins before organ damage has set in, life expectancy is essentially normal. It prevents cirrhosis, diabetes, heart failure, and the other complications of iron overload. However, it cannot reverse damage that has already occurred. Established cirrhosis, insulin-dependent diabetes, joint destruction, and hypogonadism persist even after iron levels are brought under control.
Dietary Strategies to Reduce Iron Absorption
Diet alone won’t replace phlebotomy, but strategic food choices can slow iron accumulation between sessions and potentially reduce how often you need blood drawn. The most impactful dietary change is limiting red meat. Animal proteins contain both heme iron (which is highly absorbable) and “meat factors” that boost absorption of non-heme iron from other foods in the same meal.
Alcohol is a double hit: it directly increases iron absorption in the gut and simultaneously suppresses hepcidin production in the liver, compounding the very defect that causes hemochromatosis. Abstaining from alcohol is one of the most consistently recommended dietary measures. Fructose also enhances iron absorption, possibly by converting iron into a form that’s easier for intestinal cells to take up. This applies to both added sugars and, to a lesser extent, fruit juices consumed with meals.
A plant-forward eating pattern offers natural protection. Vegetables, legumes, and whole grains contain compounds like phytates and polyphenols that bind iron in the gut and reduce its absorption. Eating fresh fruits between meals rather than with meals allows you to get their nutritional benefits while minimizing the fructose-driven iron boost. Avoiding iron-fortified cereals and iron supplements is also important, as these add unnecessary dietary iron that your body is already too efficient at absorbing.